Journal of Hepatology
Volume 48, Issue 5 , Pages 774-779 , May 2008

Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study

  • Rubén Terg

      Affiliations

    • Unidad de Hígado, Hospital de Gastroenterología “Dr. Bonorino Udaondo”, Sección Hepatología, Av. Caseros 2061, 1264 Buenos Aires, Argentina
    • Corresponding Author InformationCorresponding author. Fax: +54 11 4304 0006.
    • ,
  • Eduardo Fassio

      Affiliations

    • Hospital Prof. Alejandro Posadas, Buenos Aires, Argentina
    • ,
  • Mónica Guevara

      Affiliations

    • Hospital Clinic Barcelona, Ciberehd, Ciber de Enfermedades Hepaticas y Digestivas, España, Universidad del Salvador, Buenos Aires, Argentina
    • Mónica Guevara is supported by a grant from Fondo de Investigación sanitaria 01/3045.
    • ,
  • Mariano Cartier

      Affiliations

    • Unidad de Hígado, Hospital de Gastroenterología “Dr. Bonorino Udaondo”, Sección Hepatología, Av. Caseros 2061, 1264 Buenos Aires, Argentina
    • ,
  • Cristina Longo

      Affiliations

    • Hospital Prof. Alejandro Posadas, Buenos Aires, Argentina
    • ,
  • Romina Lucero

      Affiliations

    • Unidad de Hígado, Hospital de Gastroenterología “Dr. Bonorino Udaondo”, Sección Hepatología, Av. Caseros 2061, 1264 Buenos Aires, Argentina
    • ,
  • Cristina Landeira

      Affiliations

    • Hospital Prof. Alejandro Posadas, Buenos Aires, Argentina
    • ,
  • Gustavo Romero

      Affiliations

    • Unidad de Hígado, Hospital de Gastroenterología “Dr. Bonorino Udaondo”, Sección Hepatología, Av. Caseros 2061, 1264 Buenos Aires, Argentina
    • ,
  • Nora Dominguez

      Affiliations

    • Hospital Prof. Alejandro Posadas, Buenos Aires, Argentina
    • ,
  • Alberto Muñoz

      Affiliations

    • Unidad de Hígado, Hospital de Gastroenterología “Dr. Bonorino Udaondo”, Sección Hepatología, Av. Caseros 2061, 1264 Buenos Aires, Argentina
    • ,
  • Diana Levi

      Affiliations

    • Unidad de Hígado, Hospital de Gastroenterología “Dr. Bonorino Udaondo”, Sección Hepatología, Av. Caseros 2061, 1264 Buenos Aires, Argentina
    • ,
  • Carlos Miguez

      Affiliations

    • Unidad de Hígado, Hospital de Gastroenterología “Dr. Bonorino Udaondo”, Sección Hepatología, Av. Caseros 2061, 1264 Buenos Aires, Argentina
    • ,
  • Raquel Abecasis

      Affiliations

    • Unidad de Hígado, Hospital de Gastroenterología “Dr. Bonorino Udaondo”, Sección Hepatología, Av. Caseros 2061, 1264 Buenos Aires, Argentina

Received 6 July 2007 ,Revised 27 December 2007 ,Accepted 16 January 2008.

References 

  1. García Tsao G. Spontaneous bacterial peritonitis. Gastroenterol Clin North Am. 1992;21:257–275
  2. Caly W, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993;18:353–358
  3. Pinzello G, Simonetti R, Craxi A, Di Piazza S, Spano C, Pagliaro L. Spontaneous bacterial perotinitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology. 1983;3:545–549
  4. Levi D, Terg R, Podesta A, Abecasis R, Deglee G, Raffaelli C. Infecciones bacterianas en el paciente cirrótico. Gastroenterologia y Hepatología. 1989;12:384–388
  5. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz del Arbol L, et al. Effects of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–409
  6. Ginés P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12:716–724
  7. Tito LI, Rímola A, Ginés P, Llach J, Arroyo V, Rodés J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology. 1988;8:27–31
  8. Silvain C, Besson I, Ingrand P, Mannant PR, Fort E, Beuchant M. Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis. J Hepatol. 1993;19:188–189
  9. Terg R, Levi D, Lopez P, Rafaelli C, Rojter S, Abecasis R, et al. Analysis of clinical course and prognosis of culture positive spontaneous bacterial peritonitis and neutrocytic ascites. Evidence of the same disease. Dig Dis Sci. 1992;37:1499–1504
  10. Bernard B, Grangé GJ, Khac E, Amio X, Opolon P, Poynard T. Antibiotics prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655–1661
  11. Hou M, Lin H, Liu T, Kuo B, Lee F, Chang F, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology. 2004;39:746–753
  12. Llach J, Rimola A, Navasa M, Gines P, Salmeron JM, Gines A, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology. 1992;16:724–727
  13. Runyon B. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology. 1986;91:1343–1346
  14. Novella M, Solá R, Soriano G, Andreu M, Gana J, Ortiz J, et al. Continuous vs. inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis in cirrhotic patients with norfloxacin. Hepatology. 1997;25:532–536
  15. Grange JD, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, et al. Primary prophylaxis of bacterial infections with norfloxacin in cirrhotic patients with ascites: results of a double-blind, placebo-controlled trial. J Hepatol. 1998;29:430–436
  16. Rolachon A, Cordier L, Bacq Y, Nousbaum JB, Franza A, Paris JC, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology. 1995;22:1171–1174
  17. Singh N, Gayowski T, Yu VL, Wagener MM. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomised trial. Ann Intern Med. 1995;122:595–598
  18. Guarner C, Solá R, Soriano G, Andreu M, Novella M, Vila M, et al. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotic with low ascitic fluid protein levels. Gastroenterology. 1999;117:414–419
  19. Fernandez J, Navasa M, Planas R, Montoliu S, Montfort D, Soriano G, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improve survival in cirrhosis. Gastroenterology. 2007;133:818–824
  20. Singh N, Wagener M, Gayowski T. Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit. Clin Microbiol Infect. 2003;9:531–537
  21. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140–148
  22. Dupeyron C, Mangeney N, Sedrati L, Campillo B, Fouet P, Leluan G. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother. 1994;38:340–344
  23. Campillo B, Dupeyron C, Richardet J, Mangeney N, Leluan G. Epidemiology of severe hospital acquired infections in patients with liver cirrhosis: effects of long term administration of norfloxacin. Clin Infect Dis. 1998;26:1066–1070
  24. Cirera I, Bauer T, Navasa M, Vila J, Grande L, Taura P, et al. Bacterial translocation of enteric organism in patients with cirrhosis. J Hepatol. 2001;34:32–37
  25. Runyon B, Borzio M, Young S, Squier S, Guarner C, Runyon M. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation and survival in an animal model of cirrhosis. Hepatology. 1995;21:1719–1724
  26. Llovet J, Bartolí R, Planas R, Viñado B, Arnal J, Ojanguren I, et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to haemorrhagic shock. Hepatology. 1996;23:781–787
  27. Chin-Dusting J, Rasaratnam B, Jennings G, Dudley F. Effect of fluoroquinolone on the enhanced nitric oxide induced peripheral vasodilation seen in cirrhosis. Ann Int Med. 1997;127:985–988
  28. Rasaratnam B, Kaye D, Jenning G, Dudley F, Chin-Dustin J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. Ann Intern Med. 2003;139:186–193

☆ The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the drug involved either in the past or present and they did not receive funding from the manufacturers to carry out their research. Trial registration number is CCT-NAPN-16065.

☆☆ This study was supported by a grant from the Consejo de Investigación en Salud del Gobierno de la Ciudad de Buenos Aires.

PII: S0168-8278(08)00082-2

doi: 10.1016/j.jhep.2008.01.024

Journal of Hepatology
Volume 48, Issue 5 , Pages 774-779 , May 2008

Article Tools

* Image Usage & Resolution